Edwards J , Malaurie E , Kondrashov A , Long J , de Moor CH , Searle MS , Emsley J .

076179 Wellcome Trust , BB/F013663/1 Biotechnology and Biological Sciences Research Council , BB/G001847/1 Biotechnology and Biological Sciences Research Council

	Figure 1. Schematic representation of the protein constructs used in this study and an indication of domain boundaries. The position of the RRMs are shown shaded. Residue Ser28 represents the proposed Akt phosporylation site in RRM1.
	Figure 2. The first 187 amino acids of CELF1 are sufficient for specific binding to natural and synthetic binding sites. (a) UV-crosslinking of BSA control (C), full length CELF1 (FL), T353 (T) with radioactive maskin 3′-UTR (Msk), a truncated cyclinB1 3′-UTR (xxsB1) and a Control RNA (Bluescript polylinker transcript). Sizes of crosslinked bands are indicated. (b) UV-Crosslinking competition assay. The maskin 3′-UTR was competed with synthetic EDEN15. Radioactive control RNA (Bluescript: BS) or maskin 3′-UTR with EDEN15 in the indicated molar ratios were incubated with T187 and covalently crosslinked using by UV light. (c) Gel retardation assay with T187 EDEN15, EDEN11 and EDEN7, as well as with the AU rich element (ARE15) incubated in buffer A. An amount of 50 nM of RNA end labelled with γ-P32-ATP was incubated with increasing concentration of t187 protein, ratio RNA: protein from 1:0 to 1:100. Slender arrows indicate free RNA, thick arrows complexes induced by the protein. (d) Gel retardation of 45 nM GUCU15 with increasing concentrations of T187 in buffer B. (e) Gel retardation of 45 nM EDEN19 with increasing concentrations of T187 in buffer B.
	Figure 3. CELF1 RNA complex gel filtration profiles. (a) Plot of UV absorbance versus elution volume for T187 protein (blue) with RNA EDEN15 (red) mixed at two different molar ratios, 1:0.25 (pink); 1:1 (green), 1:2 (turquoise). (b) CELF1 RRM1 RNA complex gel filtration profiles. In blue RRM1 and in red EDEN7 alone. Different ratios RRM1:EDEN7: 1:0.25 (pink); 1:0.5 (orange); 1:1 (green) and 1:2 (turquoise).
	Figure 4. 2D 1H/15N-TROSY NMR spectra of T187 (a) and overlayed spectra of RRM1 (red) and RRM2 (blue) in (b) showing that the longer construct is well represented by the sum of the spectra of the individual domains, except for a few perturbations at the domain boundaries. Spectra were collected at 298 K in 25 mM phosphate buffer, 50 mM NaCl, 10% D2O (v/v), pH 7.0 with protein sample concentrations in the range 400–500 µM.
	Figure 5. NMR CSP plots for the binding of EDEN 7 (UGUUUGU) and CUGCUG to the two isolated RRMs. In (a) and (b), EDEN7 binding to RRM1 is illustrated, and in (c) and (d), binding of CUGCUG to RRM1 and RRM2. In each case an arbitrary cut-off of 0.1 ppm is shown by the dotted line with residues showing CSPs > 0.1 ppm individually labelled. In addition, proline residues are marked with a black dot and residues which broaden and disappear during the titration are marked with an arrow head. Along the top of the figure the relative position of the protein secondary structure is indicated.
	Figure 6. Structural representation of the CSPs mapped to the surface of the RRM1 (a), RRM2 (b) and T187 (c, d) for the RNA indicated. The magnitude of the CSPs is shown on a red to grey scale (largest perturbations shown in brightest red). Residues which broaden and disappear are marked in yellow, as particularly evident for the RRM1 domain of T187 on binding EDEN7.
	Figure 7. NMR CSP plots for the binding of EDEN15 (a) and CUG15 (b) to T187. In each case an arbitrary cut-off of 0.1 ppm is shown by the dotted line with residues showing CSPs > 0.1 ppm individually labelled. In addition, residues which broaden and disappear during the titration are marked with an arrow head. No assignments were obtained for proline residues and these are marked with a black dot. Along the top of the figure the relative position of the protein secondary structure is indicated with the domain boundary between RRM1 and RRM2 shown at residue 110. Representative portions of the 1H/15N TROSY spectra from the two titrations are shown in (c) and (d). In particular, residue C150 in RRM2 is perturbed by the binding of EDEN15 (c), but not by CUG15 (d). Five TROSY spectra are overlayed in each case representing protein:RNA ratios in the range 1:0–1:1. (e) Similar overlayed portions of the 1H/15N TROSY spectrum of T187 showing the limiting CSPs for Cys61 (RRM1) and Cys150 (RRM2) at binding saturation with a series of related RNA sequences containing different U spacers UGU(U)xUGU, where x = 1–7. (f) Histogram plot showing the CSP data from (e) for Cys61 and Cys150 with the CSPs for RRM1 reaching a plateau between x = 2–5; longer U spacers (x = 6 and 7), or a very short spacer (x = 1) result in a reduction in binding affinity for RRM2 but little difference in the shift of Cys61 in RRM1. (g) Binding isotherms at 298 K from ITC studies of T187 with UGU(U)xUGU sequences where x = 1, 2 and 6. The shortest sequence (x = 1) shows a biphasic binding behaviour whereas the two other sequences (x = 2 and 4) fit to a 1:1 binding model.
	Figure 8. Schematic representation of the binding of RRM1, RRM2 and T187 to RNA substrates. (a) EDEN7 is able to accommodate two RRM1s on adjacent UGU sites, but only a single RRM2 can bind to the same sequence, suggesting specificity for a UGUU binding site. (b) EDEN7 is too short to bind the two RRMs of T187 in tandem, instead we observe an interaction through RRM1 which could be at either of the two UGU sites (one shown). (c) Binding of T187 to both sites of the consensus GRE sequence (EDEN11) with RRM2 bound at the 5′-terminal UGUU site. The spacer sequence of 5 nt between the tandem UGU sites results in high affinity binding. (d) Possible interaction of full-length CELF1 with a GU-rich substrate with RRM1 and RRM2 bound as for the consensus sequence in (c); the long linker between RRM2 and RRM3 permits considerable conformational flexibility in binding a third UGU site up or down stream (position of arrows), or even to the looped-out spacer sequence between the RRM1 and RRM2 binding sites.

Baldwin, Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells. 2004, Pubmed

Baldwin, Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells. 2004, Pubmed
Barreau, Protein expression is increased by a class III AU-rich element and tethered CUG-BP1. 2006, Pubmed
Barreau, Mammalian CELF/Bruno-like RNA-binding proteins: molecular characteristics and biological functions. 2006, Pubmed
Bonnet-Corven, An analysis of the sequence requirements of EDEN-BP for specific RNA binding. 2002, Pubmed , Xenbase
Castle, Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines. 2008, Pubmed
Cibois, A strategy to analyze the phenotypic consequences of inhibiting the association of an RNA-binding protein with a specific RNA. 2010, Pubmed , Xenbase
Cosson, Oligomerization of EDEN-BP is required for specific mRNA deadenylation and binding. 2006, Pubmed , Xenbase
Delaunay, The Drosophila Bruno paralogue Bru-3 specifically binds the EDEN translational repression element. 2004, Pubmed , Xenbase
de Moor, Cytoplasmic polyadenylation elements mediate masking and unmasking of cyclin B1 mRNA. 1999, Pubmed , Xenbase
de Moor, The Mos pathway regulates cytoplasmic polyadenylation in Xenopus oocytes. 1997, Pubmed , Xenbase
Ezzeddine, EDEN-dependent translational repression of maternal mRNAs is conserved between Xenopus and Drosophila. 2002, Pubmed , Xenbase
Faustino, Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment. 2005, Pubmed
Gautier-Courteille, EDEN-BP-dependent post-transcriptional regulation of gene expression in Xenopus somitic segmentation. 2004, Pubmed , Xenbase
Graindorge, Identification of CUG-BP1/EDEN-BP target mRNAs in Xenopus tropicalis. 2008, Pubmed , Xenbase
Huichalaf, Regulation of the promoter of CUG triplet repeat binding protein, Cugbp1, during myogenesis. 2007, Pubmed
Iakova, Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fate. 2004, Pubmed
Kalsotra, A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. 2008, Pubmed
Kress, Inactivation of CUG-BP1/CELF1 causes growth, viability, and spermatogenesis defects in mice. 2007, Pubmed
Lee, Pathogenic mechanisms of myotonic dystrophy. 2009, Pubmed
Legagneux, Substrate-specific regulation of RNA deadenylation in Xenopus embryo and activated egg extracts. 1995, Pubmed , Xenbase
Lyon, Bruno protein contains an expanded RNA recognition motif. 2009, Pubmed
Marquis, CUG-BP1/CELF1 requires UGU-rich sequences for high-affinity binding. 2006, Pubmed , Xenbase
Meijer, Translational control of maskin mRNA by its 3' untranslated region. 2007, Pubmed , Xenbase
Moraes, CUG-BP binds to RNA substrates and recruits PARN deadenylase. 2006, Pubmed , Xenbase
Mori, Quantitative analysis of CUG-BP1 binding to RNA repeats. 2008, Pubmed
Mukhopadhyay, Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. 2003, Pubmed
Nakamura, Drosophila cup is an eIF4E binding protein that associates with Bruno and regulates oskar mRNA translation in oogenesis. 2004, Pubmed
Paillard, c-Jun ARE targets mRNA deadenylation by an EDEN-BP (embryo deadenylation element-binding protein)-dependent pathway. 2002, Pubmed , Xenbase
Paillard, EDEN and EDEN-BP, a cis element and an associated factor that mediate sequence-specific mRNA deadenylation in Xenopus embryos. 1998, Pubmed , Xenbase
Paillard, A functional deadenylation assay identifies human CUG-BP as a deadenylation factor. 2003, Pubmed , Xenbase
Salisbury, Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1. 2008, Pubmed
Teplova, Structural insights into RNA recognition by the alternate-splicing regulator CUG-binding protein 1. 2010, Pubmed
Timchenko, RNA CUG-binding protein 1 increases translation of 20-kDa isoform of CCAAT/enhancer-binding protein beta by interacting with the alpha and beta subunits of eukaryotic initiation translation factor 2. 2005, Pubmed
Timchenko, Age-specific CUGBP1-eIF2 complex increases translation of CCAAT/enhancer-binding protein beta in old liver. 2006, Pubmed
Timchenko, CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms. 1999, Pubmed
Timchenko, Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. 2004, Pubmed
Timchenko, Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. 1996, Pubmed
Tsuda, Structural basis for the sequence-specific RNA-recognition mechanism of human CUG-BP1 RRM3. 2009, Pubmed
Vlasova, Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1. 2008, Pubmed
Vlasova, Posttranscriptional regulation of gene networks by GU-rich elements and CELF proteins. 2008, Pubmed
Zhang, The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy. 2008, Pubmed